ArticleOncotarget2013

CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.

Audrey Astori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.